Translated automatically – community improvements welcome.
Vigabatrin
Vigabatrin is an anticonvulsant that increases GABA levels in the brain through irreversible inhibition of GABA transaminase, thereby reducing neuronal excitability. It is primarily used for the treatment of certain forms of epilepsy. Side effects may include visual disturbances, which is why regular ophthalmological monitoring is recommended.
Mechanism of Action
- GABA transaminase inhibitor
Names / Identifiers
IUPAC: Vigabatrin
Mechanism of Action
Vigabatrin wirkt als irreversible Hemmung des Enzyms GABA-Transaminase, was zu einer Erhöhung der GABA-Konzentration im Gehirn führt.
Effects
Effects described from scientific sources. Individual experiences vary.
Dosage
Individual sensitivity varies. Not a dosage recommendation.
Duration
Risks & Warnings
Warnings
- Hypersensitivity to Vigabatrin.
- Severe liver disease.
Known Risks
- medium
- Mögliche Nebenwirkungen umfassen Schwindel, Müdigkeit und Gewichtszunahme.
Safer Use
- Regular medical monitoring recommended.
- Slow dose adjustment to minimize side effects.
Harm reduction tips do not replace medical advice.
Known Interactions
- May interact with other antiepileptics.
- Caution when taken concurrently with sedatives.
This list is not exhaustive. Interactions can have unpredictable effects.
Legal Status
Not legal advice. Status may change.
Entdecken
Ähnliche Substanzen
Basierend auf Substanzklasse, Rezeptoren, Wirkmechanismen und Wirkprofil.